Ignite Creation Date:
2024-05-06 @ 1:27 AM
Last Modification Date:
2024-10-26 @ 11:04 AM
Study NCT ID:
NCT01816035
Status:
COMPLETED
Last Update Posted:
2017-05-23
First Post:
2013-03-19
Brief Title:
Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| HER2Neu Positive |
| Recurrent Breast Carcinoma |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
Keywords: